NRP Thermoregulation and Temperature Management 2

Question 1

Therapeutic hypothermia (controlled cooling) is the established neuroprotective treatment for which neonatal condition?

Accepted Answer

Hypoxic-ischemic encephalopathy (HIE)

Answer

Severe respiratory distress syndrome

Answer

Neonatal sepsis with multiorgan failure

Answer

Severe jaundice (hyperbilirubinemia)

Question 2

What is the standard target core temperature for whole-body therapeutic hypothermia in eligible neonates?

Accepted Answer

33-34°C (91.4-93.2°F)

Answer

30-31°C (86.0-87.8°F)

Answer

35-36°C (95.0-96.8°F)

Answer

37-38°C (98.6-100.4°F)

Question 3

For how long is therapeutic hypothermia typically maintained in eligible neonates with HIE?

Accepted Answer

72 hours

Answer

24 hours

Answer

48 hours

Answer

96 hours

Question 4

Which of the following clinical findings may indicate hypothermia in a newborn?

Accepted Answer

Poor feeding, lethargy, and cold extremities

Answer

Flushed skin and tachycardia

Answer

Hypertension and bounding pulses

Answer

Hyperthermia and seizures

Question 5

Hyperthermia (temperature >38°C) during or after neonatal resuscitation is associated with which outcome?

Accepted Answer

Increased risk of brain injury and worsened outcomes

Answer

Improved neurological outcomes

Answer

Reduced risk of seizures

Answer

Faster restoration of normal cardiorespiratory function

Question 6

When a preterm infant is placed in both a polyethylene wrap AND on a chemical warming mattress, the primary concern is:

Accepted Answer

Risk of overheating (hyperthermia)

Answer

Increased risk of skin infection

Answer

Impaired umbilical access for procedures

Answer

Reduced effectiveness of chest compressions

Question 7

Which metabolic complication is commonly caused by cold stress and hypothermia in newborns?

Accepted Answer

Hypoglycemia

Answer

Hyperglycemia

Answer

Metabolic alkalosis

Answer

Hypernatremia